EUROLAB
fda-guidance-on-dermal-sensitization-risk-assessment
Dermatological & Sensitivity Testing AFNOR BP X30-221 In Vivo Human Skin Testing ProceduresASTM D2979 Assessment of Skin Sensitization PotentialASTM D4236 Labeling of Cosmetic Products for Skin SafetyASTM D6125 Evaluation of Skin Sensitization Using In Vitro ModelsASTM D6977 Evaluation of Skin Contact AllergensASTM E1490 Evaluation of Allergic Contact DermatitisASTM E2711 Human Repeat Insult Patch Test (HRIPT) with Extended ProtocolASTM E2753 Human Repeat Insult Patch Test (HRIPT)ASTM F2312 Evaluation of Patch Test Allergen ReleaseCOLIPA Guidelines for Skin Compatibility TestingEN 16820 Test Method for Skin Sensitization PotentialEN 1811 Determination of Nickel Release from Skin-Contact ProductsEN ISO 10993-10 Assessment of Skin IrritationEN ISO 10993-18 Chemical Characterization for Dermal SafetyEN ISO 10993-21 Evaluation of Skin Irritation from Medical Device ExtractsEN ISO 10993-5 Cytotoxicity Testing on Skin CellsEP 5.1.6 Evaluation of Dermatological Safety of CosmeticsFDA 21 CFR 820 Quality System Regulation for Dermal DevicesFDA 21 CFR Part 807 Sensitivity Testing of Topical ProductsFDA Guidance for Dermatological Testing of Topical ProductsISO 105-A02 Colorfastness to Artificial Light on SkinISO 10993-1 Biological Evaluation of Medical Devices - Dermal AspectsISO 10993-10 Evaluation of Skin Irritation and SensitizationISO 10993-11 Toxicity Testing Related to Skin ContactISO 10993-12 Sample Preparation for Dermal TestingISO 10993-16 Toxicokinetic Testing of Substances in Dermal ExposureISO 10993-17 Toxicological Risk Assessment for Dermal ProductsISO 10993-19 Evaluation of Allergic Contact Dermatitis in Skin ProductsISO 10993-20 Dermal Toxicology Testing MethodsISO 10993-22 Evaluation of Sensitization from Skin Contact DevicesISO 10993-23 Evaluation of Phototoxicity and PhotoallergyISO 11137 Sterilization Validation of Dermal DevicesISO 11930 Preservative Effectiveness for Sensitive Skin ProductsISO 14155 Clinical Investigation of Medical Devices on SkinISO 15223-1 Symbols for Dermal Medical DevicesISO 15223-1 Symbols for Indicating Skin Contact in Medical DevicesISO 16128 Guidelines on Natural and Organic Cosmetic IngredientsISO 16128-1 Guidelines on Natural and Organic Cosmetics Part 1ISO 16128-2 Calculation of Natural Ingredient Content in Skin ProductsISO 16128-3 Methodologies for Determining Organic Content in Skin CareISO 16134 Human Repeat Insult Patch Test GuidanceISO 16134-2 Guidance for Patch Test Interpretation in Skin TestingISO 17516 Microbiological Limits for Skin ProductsISO 21404 Testing for Skin Contact AllergensISO 21486 Risk Assessment for Skin Contact MaterialsISO 22444 Measurement of Skin Moisture ContentISO 22715 Labeling Requirements for Skin and Cosmetic ProductsISO 22716 Good Manufacturing Practices for Dermatological ProductsISO 22716-1 Good Manufacturing Practices for Skin Care ProductsISO 23975 Patch Test Protocols for Dermatological ProductsISO 24441 In Vitro Determination of Sun Protection Factor (SPF)ISO 24442 Evaluation of Human Skin Irritation PotentialISO 24443 In Vitro Assessment of Sunscreen Efficacy on SkinISO 24443 In Vitro SPF Testing for SunscreensISO 24443 In Vitro UV Protection Factor Testing for SunscreensISO 24443 UV Protection Testing for Sensitive Skin FormulationsISO 3160-2 Compression Testing on Skin Contact MaterialsISO 3175-4 Analysis of Volatile Components Affecting Skin SensitivityISO 8124-6 Safety Requirements for Toys Affecting SkinISO/TR 16181 Guidelines on Skin Compatibility of CosmeticsISO/TR 16271 Guidelines on Safety Assessment for Skin Contact MaterialsISO/TR 19218 Dermatological Safety Data ManagementISO/TR 19930 Development of Dermal Sensitization AssaysISO/TR 22219 Testing of Skin Barrier FunctionISO/TR 29622 Allergens in Cosmetics and Personal Care ProductsJIS K 5600-5-7 Patch Test Methods for Skin SensitivityOECD TG 405 Acute Dermal Irritation/Corrosion TestOECD TG 406 Skin Sensitization in AnimalsOECD TG 406 Skin Sensitization Testing in AnimalsOECD TG 437 Bovine Corneal Opacity and Permeability Test for Skin SafetyOECD TG 439 In Vitro Skin Irritation Testing for CosmeticsOECD TG 442B Local Lymph Node Assay for Skin SensitizationOECD TG 442C In Chemico Skin Sensitization Assay (DPRA)OECD TG 442D In Vitro Skin Sensitization Assay (KeratinoSens™)OECD TG 442E Human Cell Line Activation Test (h-CLAT) for Skin SensitizationOECD TG 442E In Vitro Skin Sensitization Assay (h-CLAT)USP <151> Evaluation of Skin Irritation for Topical Dosage FormsUSP <151> Skin Sensitization Studies in Pharmaceuticals

Comprehensive Guide to FDA Guidance on Dermal Sensitization Risk Assessment Laboratory Testing Service Provided by Eurolab

Dermal sensitization is a critical concern for industries producing chemical-based products, as it can lead to skin irritation and allergic reactions in consumers. The US Food and Drug Administration (FDA) provides guidance on dermal sensitization risk assessment testing to ensure the safety of these products. This article will delve into the relevant standards governing this testing service, explaining the legal and regulatory framework surrounding it.

International and National Standards

Several international and national standards govern dermal sensitization risk assessment testing:

1. ISO 10993-10:2010: Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization

2. ASTM E1959-15: Standard Practice for Conducting Sensitization Testing with Hydrogen Peroxide on Materials

3. EN ISO 10993-10:2008: Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization

4. TSE (Turkish Standards Institution) EN ISO 10993-10:2008: Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization

These standards outline the requirements for conducting dermal sensitization risk assessment testing, including test methods, sample preparation, and data analysis.

Standard Development Organizations

Several organizations contribute to standard development in the field of dermal sensitization risk assessment:

1. International Organization for Standardization (ISO): Develops international standards for various industries.

2. American Society for Testing and Materials (ASTM): Develops voluntary consensus standards for materials, products, and services.

3. European Committee for Standardization (CEN): Develops European standards for various industries.

Standard Evolution and Updates

Standards evolve over time to reflect new technologies and scientific discoveries. This ensures that testing methods remain relevant and effective in assessing dermal sensitization risks.

Specific Standard Numbers and Scope

1. ISO 10993-10:2010

Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization.

2. ASTM E1959-15

Standard Practice for Conducting Sensitization Testing with Hydrogen Peroxide on Materials.

Standard Compliance Requirements

Manufacturers must comply with relevant standards when developing products subject to dermal sensitization risk assessment testing. Failure to do so can result in regulatory issues and recalls.

Industries Requiring Dermal Sensitization Risk Assessment

1. Medical Device Industry: Manufacturers of medical devices, such as implants, contact lenses, and wound dressings.

2. Pharmaceutical Industry: Producers of topical creams, ointments, and other skin-applied products.

3. Cosmetics Industry: Companies developing skincare products, hair care products, and fragrances.

Risk Factors and Safety Implications

Dermal sensitization can lead to severe skin reactions, including:

1. Irritation

2. Allergic contact dermatitis

3. Contact urticaria

These reactions can cause discomfort, skin lesions, and even long-term damage.

Quality Assurance and Quality Control Aspects

Manufacturers must implement quality assurance and quality control measures to ensure the accuracy of dermal sensitization risk assessment testing results.

Consequences of Not Performing this Test

Failure to conduct dermal sensitization risk assessment testing can result in:

1. Regulatory issues

2. Product recalls

3. Loss of customer trust

Competitive Advantages of Having this Testing Performed

By conducting dermal sensitization risk assessment testing, manufacturers can:

1. Ensure product safety and reliability

2. Comply with regulatory requirements

3. Gain a competitive advantage in the market

Cost-Benefit Analysis of Performing this Test

The benefits of performing dermal sensitization risk assessment testing far outweigh the costs.

...

Please let me know if you would like me to continue with the rest of the article or make any changes.

Need help or have a question?
Contact us for prompt assistance and solutions.

Latest News

View all

JOIN US
Want to make a difference?

Careers